Dr Ralph and Marian Falk Medical Research Trust
Historical FunderDallas, Texas · EIN 36-6975534 · Private foundation
Grants paid (2024)$8.3M
Organizations funded38
Typical grant$175,575
Total assets$197.2M
Half of its grants to organizations were between $173,839 and $284,681.
From the return
How to apply
The foundation filed the following application information (Form 990-PF Part XV, tax year 2024):
| Contact | TIMOTHY QUINN - BANK OF AMERICA |
|---|---|
| Address | 110 N WACKER DR FL 7, CHICAGO IL 60606 |
| Phone | 3128282055 |
| jbrown@hria.org or ilgrantmaking@bofa.com | |
| Form and materials | Go to hria.org/tmf/falktap/ for applications and procedures |
| Deadlines | AUGUST |
| Restrictions | MEDICAL RESEARCH TO IMPROVE TREATMENTS OF THE PAST AND EVENTUALLY FIND CURES FOR DISEASES FOR WHICH NO DEFINITE CURE IS KNOWN. MIDWEST RESEARCH LOCATION PREFERENCE. |
Copied as filed. Deadlines on a tax return describe the foundation's usual process; they are not confirmation of a current open cycle.
What it funds
Share of grant lines on the latest return, classified from the purpose each grant states.
Where it gives
100% of grants went outside Texas.
Grants paid in tax year 2024
| Recipient | Location | Purpose | Amount |
|---|---|---|---|
| Case Western Reserve University | Cleveland, OH | Immunotherapy for b cell | $355,809 |
| Yale University - School of Medicine | New Haven, CT | Making cancer cells look | $348,252 |
| Indiana University | Bloomington, IN | Pim2 modulator-multiple | $340,879 |
| Medical College of Wisconsin | Milwaukee, WI | Pain therapy - sensory | $334,583 |
| Thomas Jefferson University | Philadelphia, PA | Protacs for targeting brca | $333,333 |
| Cleveland Clinic Foundation | Cleveland, OH | Development of new drug for | $331,873 |
| Board Regents of University of Wisconsin | Milwaukee, WI | Improve diagnosis of breast | $330,487 |
| Medical College of Wisconsin | Milwaukee, WI | New drugs to treat | $315,981 |
| Universityof Minnesota | Minneapolis, MN | T3 therapy - heart failure | $308,897 |
| University of Minnesota | Minneapolis, MN | Optimized mechanism based | $284,681 |
| University of Chicago | Chicago, IL | Metastic lung cancer phase | $268,735 |
| Purdue University | West Lafayette, IN | Advancing micro rnas as | $257,044 |
| Northwestern University | Evanston, IL | Therapy for chronic kidney | $210,398 |
| University of Iowa | Iowa City, IA | Vascular health targeting | $208,319 |
| University of Minnesota | Minneapolis, MN | Systemic bacteremia - host | $203,837 |
| Cleveland Clinic Foundation | Cleveland, OH | Treatment of complex | $186,955 |
| Ohio State University | Columbus, OH | Melanoma onset & recurrence | $178,604 |
| University of Minnesota | Minneapolis, MN | Develop il-15 - malaria | $176,327 |
| Shirley Ryan Ability Lab | Chicago, IL | Restore diaphragm - nerve | $175,864 |
| Mayo Clinic | Rochester, MN | Cd-19 targeted car-msc19 in | $175,575 |
| Regents of University of Michigan | Ann Arbor, MI | Antibody cns delivery and | $175,000 |
| Case Western Reserve University | Cleveland, OH | Pharma strategy to treat | $175,000 |
| Brown University of Providence | Providence, RI | Repurposing clopidogrel to | $175,000 |
| Washington University | St Louis, MO | STEM cell derived islets | $175,000 |
| University of Cincinnati | Cleveland, OH | Develop improved method of | $175,000 |
| Loyola University of Chicago | Chicago, IL | Inhibitors for triple | $175,000 |
| Michigan State University | East Lansing, MI | Develop new odc inhibitors | $175,000 |
| Regents of University of Michigan | Ann Arbor, MI | Neuro-Cardiac mechanisms of | $175,000 |
| University of Minnesota | Minneapolis, MN | Sound waves assessment via | $173,839 |
| Children's Hospital Medical Center | Cincinnati, OH | Autoimmune arthritis | $173,769 |
| Washington University | St Louis, MO | Vagus nerve stimulation - | $173,717 |
| Brown University of Providence | Providence, RI | Gene therapy for | $173,096 |
| Indiana University | Bloomington, IN | Traumatic brain injury | $169,910 |
| Northwestern University | Evanston, IL | Antibodies treatment of | $168,188 |
| Yale University - School of Medicine | New Haven, CT | Anti vb2 antibody drug for | $161,487 |
| Ohio State University | Columbus, OH | Develop new therapy for | $151,908 |
| University of Minnesota | Minneapolis, MN | Severity measure- adductor | $150,426 |
| Indiana University | Bloomington, IN | Inhibitors-Peanut specific | $57,018 |
Giving by year
| Tax year | Grants paid | Grant lines |
|---|---|---|
| 2024 | $8,279,791 | 38 |
| 2023 | $7,805,072 | 37 |
| 2022 | $8,040,793 | 46 |
Sources
- IRS Form 990-PF, tax year 2024, filed Feb 7, 2026 - IRS e-file batch, object ID 202600389349100700
- IRS Tax Exempt Organization Search for EIN 36-6975534
- Profile updated Nov 5, 2026
Facts on this page come from the foundation's own IRS Form 990-PF filings as published by the IRS. Grantvello does not know whether a foundation is accepting proposals right now: a past grant is not an open opportunity. Always confirm current guidelines with the funder before applying.